查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1559676

全球腸道疾病檢測市場

Enteric Disease Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 158 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球腸道疾病檢測市場將達到 31 億美元

2023年全球腸道疾病檢測市場估計為22億美元，預計到2030年將達到31億美元，2023年至2030年複合年成長率為4.8%。細菌性腸道疾病檢測是本報告分析的細分市場之一，預計複合年成長率為 4.8%，到分析期結束時將達到 18 億美元。分析期間，寄生蟲腸道疾病測試領域的複合年成長率預計為4.1%。

美國市場預估達5.872億美元，中國預計複合年成長率為7.1%

2023年美國腸道疾病檢測市場預計將達到5.872億美元。中國作為世界第二大經濟體，預計到 2030 年市場規模將達到 6.575 億美元，2023-2030 年分析期間複合年成長率為 7.1%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 2.6% 和 4.4%。在歐洲，德國的複合年成長率預計為 2.7%。

全球腸道疾病檢測市場—主要趨勢與促進因素總結

腸道疾病檢測如何徹底改變公共衛生和疾病控制？

腸道疾病檢測為診斷影響胃腸道的感染疾病提供快速、準確和全面的工具，正在徹底改變公共衛生和疾病控制。由細菌、病毒和寄生蟲引起的腸道疾病是世界各地的一個主要健康問題，特別是在清潔水和衛生設施有限的地區。這些疾病會導致嚴重脫水、營養不良，甚至死亡，尤其是兒童和老年人等弱勢族群。快速且準確診斷腸道感染疾病的能力對於有效治療、遏制和預防疫情至關重要。現代腸道疾病檢測利用先進的診斷技術，如分子測定、免疫測量和次世代定序，以高靈敏度和特異性檢測多種病原體。透過使醫療保健提供者能夠快速確定胃腸道症狀的確切原因，腸道疾病檢測可以改善患者的治療結果，減少感染疾病的傳播，並幫助控制和預防全球範圍內的腸道舉措。

哪些創新正在改善腸道疾病檢測？

腸道疾病檢測的創新正在透過分子診斷、就地檢驗和多重檢測平台的進步來增強其功能。最重要的進步之一是聚合酵素鏈鎖反應（PCR）和其他核酸擴增技術的使用。這些分子診斷方法可以在數小時內識別糞便檢體中的特定細菌、病毒和寄生蟲。分子診斷的速度和準確性對於控制集體爆發和確保患者快速接受適當的治療、降低併發症和傳播的風險特別有用。

即時檢測 (POCT) 也是正在改變腸道疾病診斷的重要創新。 POCT 測試設備設計用於床邊或遠端位置，無需專門的測試設備即可提供即時結果。這種可攜式、易於使用的設備在傳統測試基礎設施不便、資源有限的地區尤其有用。 POCT能夠在現場快速診斷和治療腸道疾病，縮短治療時間並改善預後。這項創新在疫情爆發的情況下也很重要，及時辨識致病病原體可以防止疾病傳播。

多重檢測平台是腸道疾病檢測的另一項重大進展。這些系統可以從一份樣本同時檢測多種病原體，從而可以全面分析胃腸道症狀的潛在原因。多重檢測在症狀可能由多種病原體引起的情況下特別有用，例如食物中毒爆發或免疫力缺乏的患者。透過提供廣泛的診斷工具，多重測試減少了對多次單獨測試的需求，節省了時間和資源，同時允許對患者的病情進行徹底的調查。

這些創新使腸道疾病檢測更快、更準確、更容易獲得，對於有效的疾病控制和公共衛生保護至關重要。

腸道疾病檢測如何影響公眾健康和患者的治療結果？

腸道疾病檢測能夠及時診斷、治療和預防影響消化器官系統的感染疾病，對公共衛生和患者治療結果有重大影響。對於個別患者來說，準確、快速的檢測對於識別導致疾病的特定病原體並指南適當的治療至關重要。如果沒有正確的診斷，患者可能會接受無效或不適當的治療，導致長期患病、增加併發症的風險並增加醫療費用。腸道疾病檢測可以進行有針對性的治療，縮短疾病的持續時間和嚴重程度，並最大程度地減少脫水等併發症的可能性，特別是對於兒童和老年人等弱勢群體。

從公共衛生的角度來看，腸道疾病檢測對於減少感染疾病的傳播至關重要。快速識別社區中的感染疾病病原體使公共衛生當局能夠更有效地實施遏制措施，例如隔離感染者、警告公眾和追蹤污染源。在食物中毒的情況下，快速檢測可以識別受污染的食品，防止進一步感染並保護公眾健康。此外，腸道疾病檢測產生的資料還可以有助於監測工作，幫助追蹤疾病趨勢、監測新出現的病原體並評估公共衛生干預措施的有效性。

腸道疾病檢測在全球健康中也發揮著重要作用，特別是在胃腸道感染疾病負擔較高的地區。在清潔水和衛生設施有限的地區，腸道疾病是發病和死亡的主要原因。透過提供早期檢測和治療所需的工具，腸道疾病檢測支持更廣泛的努力，以減輕這些疾病的負擔並改善弱勢群體的健康。此外，在難民營等人道環境中，提供快速、準確的檢測至關重要。在那裡，腸道疾病的流行可以迅速傳播並造成毀滅性後果。

整體而言，腸道疾病檢測對公共衛生的影響是深遠的，可以改善患者的治療結果，加強疾病控制工作，並有助於預防未來的疫情爆發。

推動腸道疾病檢測市場成長的趨勢是什麼？

多種趨勢正在推動腸道疾病檢測市場的成長，包括食物中毒發生率的增加、診斷技術的進步、對快速檢測解決方案的需求不斷成長以及旨在控制感染疾病的全球公共衛生努力。食源性疾病發生率的增加是推動腸道疾病檢測需求的關鍵因素。隨著食品供應鏈日益全球化，受污染食品造成大規模疫情爆發的風險增加，人們更加重視食品安全並快速識別此類疫情，因此越來越需要可靠的遏制和遏制檢測方法。

診斷技術尤其是分子診斷技術的進步也促進了腸道疾病檢測市場的成長。更快、更準確和更具成本效益的診斷工具的開發擴大了腸道疾病檢測的可用性和可近性。基於 PCR 的檢測、次世代定序和多重平台等創新使得即使在資源匱乏的環境中也能夠以高靈敏度和特異性同時檢測多種病原體。這些進步不僅改善了患者護理，還透過為監測和疫情應對提供基本資料來支持更廣泛的公共衛生工作。

對快速測試解決方案的需求不斷成長也是推動市場成長的關鍵趨勢。在臨床和公共衛生環境中，對能夠提供快速結果以實現快速治療和介入的診斷測試的需求不斷成長。這種需求在感染疾病爆發和自然災害等緊急情況下尤其明顯，及時診斷對於防止疾病傳播和拯救生命至關重要。現場護理測試設備的開發和部署可以在現場提供快速、準確的結果，從而滿足了這一需求並促進了在各種環境中的採用。

旨在減輕腸道疾病負擔的全球公共衛生舉措，特別是在低收入和中等收入國家，也正在推動腸道疾病檢測市場的成長。世界衛生組織 (WHO) 和疾病管制與預防中心 (CDC) 等組織正在投資改善診斷服務、加強疾病監測系統並增強快速應對疫情爆發的能力的計畫。這些努力推動了對支持這些目標的先進腸道疾病檢測解決方案的需求。

此外，對抗菌素抗藥性 (AMR) 的關注正在影響腸道疾病檢測市場。隨著人們對抗生素濫用和抗藥性病原體增加的擔憂日益增加，人們越來越重視準確診斷以確保適當的治療。能夠快速識別致病病原體及其抗藥性的腸道疾病檢測對於對抗抗菌素抗藥性至關重要。

這些趨勢凸顯了腸道疾病檢測在改善公共衛生、加強疾病控制和應對感染疾病挑戰方面的重要作用。為了使腸道疾病檢測繼續成為全球醫療保健的重要組成部分，檢測技術的創新和全球健康的舉措將成為市場進一步成長和開拓的驅動力。

受訪企業範例（共12家）

  • Apollo Diagnostics
  • bioMerieux Sweden AB
  • Centre for Infectious Disease Research in Zambia（CIDRZ）
  • EntroGen, Inc.
  • Genovate Laboratories Inc.
  • Quest Diagnostics, Inc.
  • TECHLAB, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP11810

Global Enteric Disease Testing Market to Reach US$3.1 Billion by 2030

The global market for Enteric Disease Testing estimated at US$2.2 Billion in the year 2023, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Bacterial Enteric Disease Testing, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Parasitic Enteric Disease Testing segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$587.2 Million While China is Forecast to Grow at 7.1% CAGR

The Enteric Disease Testing market in the U.S. is estimated at US$587.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$657.5 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Enteric Disease Testing Market - Key Trends and Drivers Summarized

How Is Enteric Disease Testing Revolutionizing Public Health and Disease Management?

Enteric disease testing is revolutionizing public health and disease management by providing rapid, accurate, and comprehensive tools for diagnosing infections that affect the gastrointestinal tract. Enteric diseases, caused by bacteria, viruses, or parasites, are a significant global health concern, particularly in areas with limited access to clean water and sanitation. These diseases can lead to severe dehydration, malnutrition, and, in some cases, death, especially among vulnerable populations such as children and the elderly. The ability to quickly and accurately diagnose enteric infections is critical for effective treatment, containment, and prevention of outbreaks. Modern enteric disease testing leverages advanced diagnostic technologies, including molecular assays, immunoassays, and next-generation sequencing, to detect a wide range of pathogens with high sensitivity and specificity. By enabling healthcare providers to identify the exact cause of gastrointestinal symptoms promptly, enteric disease testing is improving patient outcomes, reducing the spread of infections, and supporting public health initiatives aimed at controlling and preventing enteric diseases worldwide.

What Innovations Are Enhancing the Functionality of Enteric Disease Testing?

Innovations in enteric disease testing are enhancing its functionality through advancements in molecular diagnostics, point-of-care testing, and multiplex testing platforms. One of the most significant developments is the use of polymerase chain reaction (PCR) and other nucleic acid amplification techniques, which allow for the rapid detection of genetic material from pathogens with high accuracy. These molecular diagnostic methods can identify specific bacteria, viruses, and parasites in stool samples within hours, compared to traditional culture methods that may take days. The speed and precision of molecular diagnostics are particularly valuable in managing outbreaks and ensuring that patients receive the appropriate treatment quickly, thereby reducing the risk of complications and transmission.

Point-of-care testing (POCT) is another key innovation that is transforming enteric disease diagnostics. POCT devices are designed for use at the bedside or in remote settings, providing immediate results without the need for specialized laboratory equipment. These portable, easy-to-use devices are particularly beneficial in resource-limited areas where access to traditional laboratory infrastructure may be lacking. POCT allows for the rapid diagnosis and treatment of enteric diseases in the field, reducing the time to care and improving the chances of a successful outcome. This innovation is also critical in outbreak situations, where timely identification of the causative pathogen can prevent the spread of disease.

Multiplex testing platforms represent another major advancement in enteric disease testing. These systems can simultaneously detect multiple pathogens from a single sample, providing a comprehensive analysis of potential causes of gastrointestinal symptoms. Multiplex tests are particularly useful in cases where symptoms could be caused by a variety of pathogens, such as in foodborne illness outbreaks or in immunocompromised patients. By providing a broad-spectrum diagnostic tool, multiplex testing reduces the need for multiple individual tests, saving time and resources while ensuring a thorough investigation of the patient’s condition.

These innovations are making enteric disease testing more rapid, accurate, and accessible, which is crucial for effective disease management and the protection of public health.

How Does Enteric Disease Testing Impact Public Health and Patient Outcomes?

Enteric disease testing has a profound impact on public health and patient outcomes by enabling the timely diagnosis, treatment, and prevention of infections that affect the gastrointestinal system. For individual patients, accurate and rapid testing is critical for identifying the specific pathogen responsible for their illness, which guides appropriate treatment. Without proper diagnosis, patients may receive ineffective or inappropriate treatments, leading to prolonged illness, increased risk of complications, and higher healthcare costs. Enteric disease testing allows for targeted therapy, reducing the duration and severity of the illness and minimizing the potential for complications such as dehydration, especially in vulnerable populations like children and the elderly.

From a public health perspective, enteric disease testing is essential for controlling the spread of infectious diseases. Rapid identification of pathogens in community outbreaks allows public health authorities to implement containment measures more effectively, such as isolating infected individuals, issuing public warnings, and tracing the source of contamination. In the case of foodborne illnesses, prompt testing can lead to the identification of contaminated food products, preventing further cases and protecting public health. Moreover, the data generated from enteric disease testing contribute to surveillance efforts, helping to track trends in disease incidence, monitor emerging pathogens, and evaluate the effectiveness of public health interventions.

Enteric disease testing also plays a vital role in global health, particularly in regions with high burdens of gastrointestinal infections. In areas where access to clean water and sanitation is limited, enteric diseases are a leading cause of morbidity and mortality. By providing the tools needed for early detection and treatment, enteric disease testing helps to reduce the burden of these diseases and supports broader efforts to improve health outcomes in vulnerable populations. Additionally, the availability of rapid and accurate testing is crucial in humanitarian settings, such as refugee camps, where outbreaks of enteric diseases can spread quickly and have devastating consequences.

Overall, the impact of enteric disease testing on public health is far-reaching, improving patient outcomes, enhancing disease control efforts, and contributing to the prevention of future outbreaks.

What Trends Are Driving Growth in the Enteric Disease Testing Market?

Several trends are driving growth in the enteric disease testing market, including the increasing incidence of foodborne illnesses, advancements in diagnostic technology, the rising demand for rapid testing solutions, and global public health initiatives aimed at controlling infectious diseases. The growing incidence of foodborne illnesses is a significant factor fueling the demand for enteric disease testing. As globalization of the food supply chain increases, the risk of widespread outbreaks caused by contaminated food products has risen, prompting greater emphasis on food safety and the need for reliable testing methods to quickly identify and contain such outbreaks.

Advancements in diagnostic technology, particularly in molecular diagnostics, are also contributing to the growth of the enteric disease testing market. The development of faster, more accurate, and cost-effective diagnostic tools has expanded the availability and accessibility of enteric disease testing. Innovations such as PCR-based assays, next-generation sequencing, and multiplex platforms have made it possible to detect multiple pathogens simultaneously with high sensitivity and specificity, even in low-resource settings. These advancements are not only improving patient care but also supporting broader public health efforts by providing essential data for surveillance and outbreak response.

The rising demand for rapid testing solutions is another key trend driving market growth. In both clinical and public health settings, there is a growing need for diagnostic tests that can deliver results quickly, allowing for prompt treatment and intervention. This demand is particularly acute in emergency situations, such as outbreaks or natural disasters, where timely diagnosis is critical to preventing the spread of disease and saving lives. The development and deployment of point-of-care testing devices that provide rapid, accurate results in the field are meeting this need and driving adoption in diverse settings.

Global public health initiatives aimed at reducing the burden of enteric diseases, particularly in low- and middle-income countries, are also driving growth in the enteric disease testing market. Organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) are investing in programs to improve access to diagnostics, strengthen disease surveillance systems, and enhance the capacity for rapid response to outbreaks. These efforts are increasing the demand for advanced enteric disease testing solutions that can support these goals.

Additionally, the focus on antimicrobial resistance (AMR) is influencing the enteric disease testing market. With the growing concern over the misuse of antibiotics and the rise of resistant pathogens, there is an increasing emphasis on accurate diagnosis to ensure appropriate treatment. Enteric disease testing that can rapidly identify the causative pathogen and its resistance profile is becoming essential in the fight against AMR.

These trends highlight the critical role of enteric disease testing in improving public health, enhancing disease management, and responding to the challenges posed by infectious diseases. As the market continues to evolve, innovations in testing technology and global health initiatives will likely drive further growth and development, ensuring that enteric disease testing remains a vital component of healthcare worldwide.

Select Competitors (Total 12 Featured) -

  • Apollo Diagnostics
  • bioMerieux Sweden AB
  • Centre for Infectious Disease Research in Zambia (CIDRZ)
  • EntroGen, Inc.
  • Genovate Laboratories Inc.
  • Quest Diagnostics, Inc.
  • TECHLAB, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Enteric Disease Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Global Prevalence of Enteric Diseases Spurs Demand for Rapid Diagnostic Tests
    • Growing Travel and Migration Contributing to Spread of Enteric Pathogens
    • Integration of Point-of-Care Testing Devices in Remote and Resource-Limited Settings
    • Rising Healthcare Infrastructure Investments in Emerging Economies
    • Market Trends Towards Multiplexed Testing Platforms for Simultaneous Detection
    • Future Trends: AI and Machine Learning Integration in Diagnostic Processes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Bacterial Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Bacterial Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Bacterial Enteric Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Viral Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Viral Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Viral Enteric Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Parasitic Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Parasitic Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Parasitic Enteric Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Conventional Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Conventional Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Conventional Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Molecular Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Molecular Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Molecular Diagnostic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Testing Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Enteric Disease Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Enteric Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • JAPAN
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • CHINA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • EUROPE
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Enteric Disease Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • GERMANY
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Enteric Disease Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • INDIA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Enteric Disease Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Enteric Disease Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • AFRICA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030

IV. COMPETITION